论文部分内容阅读
目的:为优化配置药品资源,合理选择和利用药品,使药品高效、安全又经济地为医疗保健服务,从而形成科学合理的药品结构。方法:采用药物利用研究的基本方法,对我院1996～1998年用药信息进行分析。以本院实际药品消耗数据为基础,按消耗药品金额排序前100位药品为重点进行动态对比分析。结果:3年中进口药比例逐年下降。1996、1997和1998年的下降幅度分别为29％、24％和19％,合资药和国产药分别上升7个百分点和3个百分点。1～100位消耗药品总金额分别占其相应年份总消耗药品金额的72％(1996年)、75％(1997年)和75％(1998年)。1996年100位内品种,在1997年淘汰34种;1997年100位内品种,在1998年淘汰24种。这两年期间平均每年淘汰29种。结论:当前医药市场药品品种多样化及竞争加剧化,医生的处方行为在药品需求中起着举足轻重的作用。选择临床必需、安全有效、价格合理、使用方便的新药是当务之急。药物经济学分析给治疗药物的选择、治疗方案的决策带来了全新的观念,把“合理”和“经济”融为一体,做到“物有所值”,是追求的目标。
Objective: To optimize the allocation of drug resources, rationally select and use drugs, so that drugs can efficiently, safely, and economically serve health care, thus forming a scientific and rational drug structure. Methods: Using the basic methods of drug utilization research, the information of medication in our hospital from 1996 to 1998 was analyzed. Based on the actual drug consumption data of this hospital, the dynamic comparison and analysis was performed focusing on the top 100 drugs ranked according to the amount of drugs consumed. Results: The proportion of imported drugs decreased year by year. The declines in 1996, 1997, and 1998 were 29%, 24%, and 19%, respectively. Joint ventures and domestic drugs increased by 7 and 3 percentage points respectively. The total amount of 1 to 100 consumable drugs accounted for 72% (1996), 75% (1997), and 75% (1998) of the total amount of drugs consumed in their respective years. In 1996, 100 species were eliminated, and 34 species were eliminated in 1997; in 1997, 100 species were eliminated, and 24 species were eliminated in 1998. The average annual elimination of 29 species during the two-year period. Conclusion: The variety and variety of drugs in the pharmaceutical market are intensifying, and doctors’ prescription behavior plays a pivotal role in drug demand. Selecting new drugs that are clinically necessary, safe and effective, reasonably priced, and easy to use are imperative. The analysis of pharmacoeconomics brings new ideas to the choice of therapeutic drugs and decision-making of treatment programs. Integrating “reasonable” and “economic” into one, “value for money” is the goal pursued.